Baxter International Inc. and Ayogo Health Inc., a behavioral science-based digital health company, announced the expansion of their partnership to support the needs of those with kidney disease through digital health solutions. Ayogo is combining LifePlan—its unique behavior-based digital platform—with Baxter’s expertise in renal care to build mobile apps and digital solutions that bring personalized, relevant, and timely support to individuals with kidney failure. Baxter also made an equity investment in Ayogo in exchange for minority interest in the company. Financial details of the agreement were not disclosed.
The companies’ initial collaboration resulted in a consumer engagement app—CKD&Me—that provides customized disease and therapy education for the individual learning needs of consumers with chronic kidney disease. CKD&Me recently launched in the United States for use on smartphones and tablets and is available in the United States on the App Store and on Google Play
While the companies continue to expand the content and features of CKD&Me, they are also building a new mobile platform for individuals using Baxter’s Sharesource remote management platform. Sharesource, which is widely used in 65 countries, has helped health care professionals remotely manage more than 17 million home dialysis treatments. The new initiative will provide individuals the ability to more proactively manage their home dialysis therapy records in partnership with their health care team.
Baxter has a portfolio of offerings that include critical care, nutrition, renal, hospital, and surgical products. Baxter offers products, technologies, and therapies available in more than 100 countries.
Ayogo Health, Inc. is a behavioral science-based company. Ayogo’s Glimpse™ Platform substantially increases activation, adherence, and persistence to therapy by tailoring content, tools and support to each person’s unique psychosocial characteristics.
This was reported by Baxter on June 29, 2020.